Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy')

Psychopharmacology

Volumn 211, Issue 1, 2010, Pages 15-25

  Vanattou Saïfoudine, Natacha ^a   McNamara, Ruth ^b   Harkin, Andrew ^a,b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Body temperature; Caffeine; Dopamine receptors; Heart rate; Locomotor activity; MDMA; Rat

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CAFFEINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BODY TEMPERATURE; BRADYCARDIA; CONTROLLED STUDY; HEART RATE; HYPERACTIVITY; HYPERTHERMIA; HYPOTHERMIA; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TACHYCARDIA;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; BODY WEIGHT; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE AGENTS; DRUG INTERACTIONS; HALLUCINOGENS; HEART RATE; LOCOMOTION; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SULPIRIDE; TIME FACTORS;

EID: 77955566628     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1864-1     Document Type: Article

References (55)

1. Abrahams TP, Cuntapay M, Varner KJ (1996) Sympathetic nerve responses elicited by cocaine in anesthetized and conscious rats. Physiol Behav 59:109-115
2. Armstrong LE, Casa DJ, Maresh CM, Ganio MS (2007) Caffeine, fluid-electrolyte balance, temperature regulation, and exercise-heat tolerance. Exerc Sport Sci Rev 35:135-140
3. Badon LA, Hicks A, Lord K, Ogden BA, Meleg-Smith S, Varner KJ (2002) Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy. J Pharmacol Exp Ther 302:898-907
4. Ball KT, Budreau D, Rebec GV (2003) Acute effects of 3, 4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D (1) and D (2) receptors. Brain Res 994 (2):203-215
5. Bankson MG, Cunningham KA (2002) Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT (1B/1D) and 5-HT (2) receptors. Neuropsychopharmacol 26 (1):40-52
6. 2 receptors: time course and functional characteristics in vivo. J Neurosci 21:9134-9141
7. 1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Res 1211:1-5
8. Blessing WW, Seaman B, Pedersen NP, Ootsuka Y (2003) Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3, 4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. J Neurosci 23:6385-6391
9. Burgess C, O'Donohoe A, Gill M (2000) Agony and ecstasy: a review of MDMA effects and toxicity. Eur Psychiatry 15:287-294
10. Camarasa J, Pubill D, Escubedo E (2006) Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug. Brain Res 1111:72-82
11. Cavero I, Massingham R, Lefevere-Borg F (1982) Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II: sites and mechanisms of action of dopamine receptor agonists. Life Sci 31:1059-1069 (Pubitemid 13243106)
12. Cavero I, Thiry C, Pratz J, Lawson K (1987) Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Clin Exp Hypertens 9:931-952 (Pubitemid 17104735)
13. 4 receptors. Neuropharmacology 44:1047-1053
14. Chitravanshi VC, Calaresu FR (1992) Dopamine microinjected into the nucleus ambiguous elicits vagal bradycardia in spinal rats. Brain Res 583:308-311
15. Cornelis MC, El-Sohemy A (2007) Coffee, caffeine, and coronary heart disease. Curr Opin Clin Nutr Metab Care 10:745-751 (Pubitemid 350293776)
16. Cragg SJ, Greenfield SA (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 17:5738-5746
17. 2 receptor activation is critical but not the expression of the unconditioned response. Brain Res 1083:85-95
18. Frantz KJ, Van Hartesveldt C (1995) Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats. Psychopharmacology (Berl) 119:299-304
19. Freedman RR, Johanson CE, Tancer ME (2005) Thermoregulatory effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacol 183:248-256
20. Gouzoulis-Mayfrank E, Daumann J (2006) The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol 20:188-193
21. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
22. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
23. 1 dopamine receptors in the medial prefrontal cortex attenuates amphetamineand methamphetamine-induced locomotor activity in the rat. Brain Res 1300:51-57
24. Harkin A, Kelly JP, Frawley J, O'Donnell JM, Leonard BE (2000) Test conditions influence the response to a drug challenge in rodents. Pharmacol Biochem Behav 65:389-398
25. Harkin A, O'Donnell JM, Kelly JP (2002a) A study of VitalView for behavioural and physiological monitoring in laboratory rats. Physiol Behav 77:65-77
26. Harkin A, Connor TJ, O'Donnell JM, Kelly JP (2002b) Physiological and behavioral responses to stress: what does a rat find stressful? Lab Anim (NY) 31:42-50
27. Hasegawa H, Meeusen R, Sarre S, Diltoer M, Piacentini MF, Michotte Y (2005) Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. J Appl Physiol 99:1397-1401
28. Jackson DM, Westlind-Danielsson A (1994) Dopamine receptors: molecular biology, biochemistry and behavioural aspects. Pharmacol Ther 64:291-370 (Pubitemid 124003168)
29. Kaneno S, Fukamauchi F, Komatsu H, Koyama K, Ikawa K (2001) Reversal effect of sulpiride on rotational behaviour of rats with unilateral frontal cortex ablation: an alternative explanation for the pharmacological mechanism of its antidepressant effect. Behav Pharmacol 12:69-73
30. Kiyatkin EA (2002) Dopamine in the nucleus accumbens: cellular actions, drug-and behavior-associated fluctuations, and a possible role in an organism's adaptive activity. Behav Brain Res 137:27-46
31. Knuepfer MM, Branch CA (1992) Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J Pharmacol Exp Ther 263:734-741
32. 4, receptors in the striatum without the involvement of action potentials. J Neurosci 20:6666-6671
33. Langer SZ (1997) 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95-99
34. Maj J, Rogóz Z, Skuza G, Kolodziejczyk K (1997) The behavioural effects of pramipexole, a novel dopamine receptor agonist. Eur J Pharmacol 324:31-37 (Pubitemid 27160905)
35. McNamara R, Kerans A, O'Neill B, Harkin A (2006) Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). Neuropharmacology 50:69-80
36. McNamara R, Maginn M, Harkin A (2007) Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration. Eur J Pharmacol 555:194-198
37. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3, 4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135 (1):170-180
38. Milroy CM, Clark JC, Forrest AR (1996) Pathology of deaths associated with "ecstasy" and "eve" misuse. J Clin Pathol 49:149-153
39. Nava F, Carta G, Gessa GL (2000) Permissive role of dopamine D2 receptors in the hypothermia induced by [delta]9-tetrahydrocan-nabinol in rats. Pharmacol Biochem Behav 66:183-187
40. Nawrot P, Jordan S, Eastwood J, Rotstein J, Hugenholtz A, Feeley M (2003) Effects of caffeine on human health. Food Addit Contam 20:1-30
41. O'Cain PA, Hletko SB, Ogden BA, Varner KJ (2000) Cardiovascular and sympathetic responses and reflex changes elicited by MDMA. Physiol Behav 70:141-148
42. O'Tuathaigh CP, Moran PM (2004) The effect of sulpiride on amphetamine-induced disruption of overshadowing in the rat. Prog Neuropsychopharmacol Biol Psychiatry 28:1249-1253
43. Paul E M P, Pamela JH, Jonathan AS (2002) Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44:15-22
44. 3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacol 31:2349-2358
45. Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2004) Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study. Addict Behav 29:743-752
46. 1 receptors increases the locomotor activity of developing rats. Eur J Pharmacol 311:103-107
47. Shioda K, Nisijima K, Yoshino T, Kuboshima K, Iwamura T, Yui K, Kato S (2008) Risperidone attenuates and reverses hyperthermia induced by 3, 4-methylenedioxymethamphetamine (MDMA) in rats. Neurotoxicology 29:1030-1036
48. 2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry 161:1620-1625
49. Vanattou-Saïfoudine N, McNamara R, Harkin A (2010) Mechanisms mediating the ability of caffeine to influence MDMA ("Ecstasy")- induced hyperthermia in rats. Br J Pharmacol (in press)
50. Velasco M, Luchsinger A (1998) Dopamine: pharmacologic and therapeutic aspects. Am J Ther 5:37-43
51. Vezina P, Blanc G, Glowinski J, Tassin JP (1991) Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopamine receptor. Eur J Neurosci 3:1001-1007
52. Von Huben SN, Lay CC, Crean RD, Davis SA, Katner SN, Taffe MA (2007) Impact of ambient temperature on hyperthermia induced by (+/-) 3, 4-methylenedioxymethamphetamine in rhesus macaques. Neuropsychopharmacol 32:673-681
53. Waddington JL, Daly SA, Downes RP, Deveney AM, McCauley PG, O'Boyle KM (1995) Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831
54. 2 receptors in the ventral striatum: multiple effects or receptor subtypes? Nihon Shinkei Seishin Yakurigaku Zasshi 17:91-95
55. 2-receptors. Yonsei Med J 35:411-419